Showing results (61-70 of 127) with videos related to
Sort By:
Pageof 13
The Review of Scientific Instruments|December 3, 2016
Asymmetries in the motional Stark effect emission on the DIII-D tokamakB S Victor, C T Holcomb, S L Allen, et al.Clinical Pharmacology and Therapeutics|May 1, 1989
Dextromethorphan and caffeine as probes for simultaneous determination of debrisoquin-oxidation and N-acetylation phenotypes in childrenW E Evans, M V Relling, W P Petros, et al.Medical and Pediatric Oncology|May 10, 2001
Circulating concentrations of IGF-I and IGFBP-3 are not predictive of incidence or clinical behavior of pediatric osteosarcomaC Rodriguez-Galindo, C A Poquette, N C Daw, et al.Investigational New Drugs|January 1, 1995
A phase I study of sulofenur in refractory pediatric malignant solid tumorsC B Pratt, L C Bowman, N Marina, et al.Medical and Pediatric Oncology|January 1, 1979
Ovarian involvement in neuroblastomaW H Meyer, G W Yu, E S Milvenan, et al.Journal of Pediatric Hematology/Oncology|April 25, 2000
Comparative renal tubular toxicity of chemotherapy regimens including ifosfamide in patients with newly diagnosed sarcomasN M Marina, C A Poquette, A M Cain, et al.Clinical Pharmacology and Therapeutics|September 1, 1991
Lower prevalence of the debrisoquin oxidative poor metabolizer phenotype in American black versus white subjectsM V Relling, J Cherrie, M J Schell, et al.Pediatric Blood & Cancer|September 25, 2004
Tumor size as a predictor of outcome in pediatric non-metastatic osteosarcoma of the extremitySue C Kaste, T Liu, C A Billups, et al.American Journal of Clinical Oncology|December 1, 1991
Phase I study of flavone acetic acid (NSC 347512, LM975) in patients with pediatric malignant solid tumorsC B Pratt, M V Relling, W H Meyer, et al.The Journal of Chemical Physics|September 28, 2013
Communication: Synperiplanar to antiperiplanar conformation changes as underlying the mechanism of Debye process in supercooled ibuprofenK Adrjanowicz, K Kaminski, M Dulski, et al.Pageof 13